Affluent Medical SAS (AFME) - Total Assets
Based on the latest financial reports, Affluent Medical SAS (AFME) holds total assets worth €59.84 Million EUR (≈ $69.96 Million USD) as of June 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Affluent Medical SAS - Total Assets Trend (2016–2024)
This chart illustrates how Affluent Medical SAS's total assets have evolved over time, based on quarterly financial data. Also see market value of Affluent Medical SAS for the company's overall valuation and market capitalisation.
Affluent Medical SAS - Asset Composition Analysis
Current Asset Composition (December 2024)
Affluent Medical SAS's total assets of €59.84 Million consist of 20.0% current assets and 80.0% non-current assets. Review Affluent Medical SAS balance sheet liabilities to assess the company's total debt and financial obligations.
| Asset Category | Amount (EUR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €1.23 Million | 2.0% |
| Accounts Receivable | €3.45 Million | 5.7% |
| Inventory | €0.00 | 0.0% |
| Property, Plant & Equipment | €1.25 Million | 2.1% |
| Intangible Assets | €15.14 Million | 24.9% |
| Goodwill | €32.20 Million | 52.9% |
Asset Composition Trend (2016–2024)
This chart illustrates how Affluent Medical SAS's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See Affluent Medical SAS stock quote for real-time trading data and today's change.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Affluent Medical SAS's current assets represent 20.0% of total assets in 2024, an increase from 6.3% in 2016.
- Cash Position: Cash and equivalents constituted 2.0% of total assets in 2024, down from 2.6% in 2016.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 76.0% of total assets, a decrease from 93.0% in 2016.
- Asset Diversification: The largest asset category is goodwill at 52.9% of total assets.
Affluent Medical SAS Competitors by Total Assets
Key competitors of Affluent Medical SAS based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
|
China | CN¥16.89 Billion |
|
Shandong Weigao Orthopaedic Device Co. Ltd. A
SHG:688161
|
China | CN¥5.19 Billion |
|
Jafron Biomedical Co Ltd
SHE:300529
|
China | CN¥5.20 Billion |
|
Ningbo David Medical Device Co Ltd
SHE:300314
|
China | CN¥1.47 Billion |
|
Beijing Succeeder Technology Inc
SHG:688338
|
China | CN¥1.78 Billion |
|
Dirui Industrial Co Ltd
SHE:300396
|
China | CN¥2.57 Billion |
|
Profound Medical Corp
TO:PRN
|
Canada | CA$62.28 Million |
|
Somnomed Ltd
AU:SOM
|
Australia | AU$79.90 Million |
Affluent Medical SAS - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.07 | 0.45 | 2.69 |
| Quick Ratio | 1.07 | 0.37 | 2.51 |
| Cash Ratio | 0.00 | 0.06 | 0.00 |
| Working Capital | €805.00K | €-7.93 Million | €4.22 Million |
Affluent Medical SAS - Advanced Valuation Insights
This section examines the relationship between Affluent Medical SAS's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 11.41 |
| Latest Market Cap to Assets Ratio | 1.81 |
| Asset Growth Rate (YoY) | 7.5% |
| Total Assets | €60.86 Million |
| Market Capitalization | $110.43 Million USD |
Valuation Analysis
Above Book Valuation: The market values Affluent Medical SAS's assets above their book value (1.81x), reflecting positive investor sentiment about the company's future prospects.
Positive Asset Growth: Affluent Medical SAS's assets grew by 7.5% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Affluent Medical SAS (2016–2024)
The table below shows the annual total assets of Affluent Medical SAS from 2016 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | €60.86 Million ≈ $71.15 Million |
+7.48% |
| 2023-12-31 | €56.62 Million ≈ $66.20 Million |
-5.66% |
| 2022-12-31 | €60.02 Million ≈ $70.17 Million |
-14.30% |
| 2021-12-31 | €70.03 Million ≈ $81.88 Million |
+8.04% |
| 2020-12-31 | €64.83 Million ≈ $75.79 Million |
-0.65% |
| 2019-12-31 | €65.25 Million ≈ $76.29 Million |
-3.18% |
| 2017-12-31 | €67.39 Million ≈ $78.79 Million |
+9.19% |
| 2016-12-31 | €61.72 Million ≈ $72.16 Million |
-- |
About Affluent Medical SAS
Affluent Medical SA, a medical technology company, develops and markets minimally invasive minimally invasive medical devices in the field of urology and structural heart in France. It offers Artus, an implantable electro-mechanical artificial sphincter that targets moderate to severe urinary incontinence; and Kalios and Epygon implants for the treatment of mitral insufficiency, as well as Kardio… Read more